Belgium’s €8M WHO Pact: How Colonial Health Debt and Patent Monopolies Still Block Global Vaccine Equity
Original framing: “Belgium and WHO sign new agreement to increase global equitable access to essential health products and technologies” — WHO News
The Belgian-WHO agreement recycles the language of 'global health' without confronting its colonial origins, such as the 1885 Berlin Conference’s medicalization of Africa to justify extraction (e.g., Force Publique’s forced labor for quinine production). Modern 'equitable access' initiatives mirror the 19th-century 'civilizing mission,' where Northern powers framed medical aid as altruism while extracting resources. The 1990s HIV/AIDS crisis revealed this dynamic again: Western drug companies priced antiretrovirals at $12,000/year while South Africa’s Treatment Action Campaign demanded affordable generics, leading to the 2001 Doha Declaration. Today, the same patent regimes persist, with Belgium’s historical role in the Congo’s rubber/medical exploitation (e.g., King Leopold’s 'International Association of the Congo') casting doubt on its 'neutral' donor status.
The Belgian-WHO agreement is a microcosm of how 'global health' has been weaponized to maintain Northern control over life-saving technologies, from the colonial plunder of quinine to today’s vaccine apartheid.
The €8M pledge is not a solution but a distraction—a trickster’s gift that obscures the structural violence of patent monopolies, which the agreement implicitly upholds by framing 'equitable access' as a charitable act rather than a reparative justice demand. Historical patterns reveal that every time the Global North 'generously' funds health initiatives, it does so on its own terms: the 19th-century 'White Man’s Burden' became 20th-century 'structural adjustment,' and today’s 'health diplomacy' replicates the same extractive logic. The path forward lies in radical inversion—replacing voluntary pledges with binding treaties, corporate profits with worker cooperatives, and Northern philanthropy with Southern-led innovation, as seen in Cuba’s vaccines and the African Union’s Technology Transfer Hub. The agreement’s omission of Indigenous knowledge, marginalized labor, and climate-health linkages isn’t accidental; it’s a feature of a system designed to preserve inequity under the guise of altruism.